RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-846
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0102300; Gene model (P.falciparum): PF3D7_0603500; Gene product: cation/H+ antiporter (CAH; pfCAX; pbCAX)
Phenotype Fertilization and ookinete; Oocyst;
Last modified: 2 November 2016, 10:50
  *RMgm-846
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 23468629
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943).
The mutant parasite was generated by
Name PI/ResearcherGuttery DS; Tewari R; Staines HM
Name Group/DepartmentCentre for Genetics and Genomics, School of Biology, Queens Medical Centre
Name InstituteUniversity of Nottingham
CityNottingham
CountryUK
Name of the mutant parasite
RMgm numberRMgm-846
Principal nameΔpbcax
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNormal gametocyte production. Normal exflagellation of male gametocytes. No ookinetes are formed. Parasites failed to develop further from ‘round’ form zygotes into mature ookinetes
OocystNormal gametocyte production. Normal exflagellation of male gametocytes. No ookinetes are formed. No oocysts are formed.
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of cation/H+ antiporter (PbCAX)

Protein (function)
Ca2+/H+ exchanger (PfCAX, also termed the Ca2+/H+ antiporter, PfCHA) has been identidied in P. falciparum. PfCAX and other apicomplexan orthologues belong to the Ca2+/cation antiporter (CaCA) superfamily CAX genes are classified into 3 subfamilies. Type II CAXs are found in fungi, Dictyostelium, and lower vertebrates and Type III CAXs are found in bacteria, while Type I CAXs include bacterial, fungal, plant and protozoan CAXs. Type I CAXs are divided into 8 subgroups (A to H) and protozoa are classified into the Type I-C phylogenetic group. Functional characterisation of CAX proteins (mainly from plants and fungi) has shown that these H+ coupled exchangers all transport Ca2+, with some being highly specific for Ca2+, whilst others mediate the transport of a broad range of additional divalent cations or, in some cases, transport additional monovalent cations. Their primary role in plants and fungi is to enable tolerance to high extracellular Ca2+concentrations, by internal sequestration of Ca2+into acidic organelles when cytosolic levels rise

Phenotype
The phenotype analyses indicate that PbCAX has no essential role in asexual blood stages. Phenotype analyses indicate that PbCAX is involved in development of the female gamete/zygote into ookinetes. Mutant parasites failed to develop further from ‘round’ form zygotes into mature ookinetes.

Additional information
Phenotype analyses indicate that PbCAX is involved in development of the female gamete/zygote into ookinetes. Mutant parasites failed to develop further from ‘round’ form zygotes into mature ookinetes.
Δpbcaxx female gametes/zygotes were still round in form, fewer in number and were often smaller in size and had degenerated membranes. They often had diffuse nuclei, suggestive of possible necrosis or late stage apoptosis.
Evidence is presented that this phenotype could be rescued by removal of extracellular Ca2+ from the culture medium in which ookinetes were cultured. Ca2+ was removed by adding the Ca2+ chelator EGTA (ethylene glycol tetraacetic acid) to the culture medium.

Analysis of a mutant expressing a C-terminal GFP-tagged version of PbCAX (RMgm-848) showed only very low level, diffuse fluorescence signals in asexual blood stages, with stronger parasite-associated GFP signals observed only on rare occasions. Stronger GFP signal was observed in female but not male gametocytes and the same was true for gametes. Thus, the asexual parasites with stronger GFP signal may have been immature female gametocyte stages. Good GFP signal was also observed in zygotes, ookinetes and oocysts. Little GFP-signal co-localised with Mito-Tracker, used as a marker for the parasite mitochondrion.

In vitro cross-fertilisation experiments were performed of Δpbcax gametes with either wild type male (nek2- or nek4- males) or wild type female gametes (map2-females). Crossing Δpbcax with nek2- or nek4- resulted in recovered ookinete conversion of 14 and 13%, respectively. This is due to the fertilisation of female Δpbcax parasites by functional nek2- or nek4- male gametes. However, crossing Δpbcax with map2- resulted in recovered ookinete conversion of 42%. This is due to the fertilisation of functional map2-female gametes by male Δpbcax parasites. These data suggest that PbCAX activity, while not specific, is predominantly important to female gametes.

Analysis of P. falciparum PfCAX has demonstrated Ca2+/H+ exchange activity, an ability to exchange a limited range of other divalent cations, and a high transport capacity but low affinity (Km value of ,2 mM) for Ca2+, when expressed in Xenopus oocytes. In vivo studies characterising PfCAX were consistent with an atypical localisation to the inner mitochondrial membrane, and an atypical function, where the protein provides a pathway for removal of Ca2+ from this organelle back into the parasite cytosol.

The studies on P. berghei PbCAX provided no evidence for a location or role in mitochondria.

PfCAX has a predicted mitochondrial targeting sequence at residues 11–18 (YVRRTISQ), consistent with mitochondrial localisation, and this is conserved throughout the apicomplexan CAXs. Interestingly, this protein sequence has been identified in phosphoproteomic studies, using preparations derived from mature trophozoite-infected erythrocytes, and two of these residues, T15 and S17, are putative phospho-acceptor sites (with ascores of 1000, suggesting the annotations have a high degree of confidence). Phosphorylation of the S17 residue of PbCAX has also been reported, in a similar study, using ookinete preparations (available on GeneDB). The homologous protein region of TgCAX was also identified in tachyzoite preparations, although it contained no phosphorylated sites. However, neighbouring residues at positions S26, S27 and T46 were identified as being phosphorylated, albeit with lower ascores of 19, 13 and 6, respectively. Previous work has demonstrated that phosphorylation of the mitochondrial signal sequence of 29,39-cyclic nucleotide-39-phosphodiesterase 2 (CNP2) alters its localisation so that it is retained in the cytoplasm and its possible a similar mechanism could alter the location of apicomplexan CAXs. However, the localisation evidence presented for PbCAX provides little evidence for mitochondrial function of CAXs in apicomplexan parasites.

Other mutants
RMgm-847: an independent mutant lacking expression of PbCAX and expressing GFP under control of the constitutieve eef1a promoter
RMgm-848:a mutant expressing a C-terminal GFP-tagged version of PbCAX


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0102300
Gene Model P. falciparum ortholog PF3D7_0603500
Gene productcation/H+ antiporter
Gene product: Alternative nameCAH; pfCAX; pbCAX
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid ApaI, NotI
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe pbcax knock-out vectors were constructed for a double cross-over homologous recombination in the pBS-DHFR plasmid that contains a Toxoplasma gondii dhfr/ts cassette conferring resistance to pyrimethamine. The knock-out construct was generated by inserting 507 bp of the pbcax 5' untranslated (UTR) region upstream and 497 bp of the pbcax 3' UTR region downstream of the dhfr cassette. The final knock-out construct was digested with ApaI and NotI to release the fragment for transfection. Transfection of P. berghei parasites with the knock-out construct was carried out in both wild-type parasites and in a line that constitutively expresses cytosolic GFP
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1CCCCGGGCCCCAGTAATGATGTTCCCATAC
Additional information primer 1N0431
Sequence Primer 2GGGGAAGCTTCTCAATACATTCATTGTATGGCTC
Additional information primer 2N0432
Sequence Primer 3CCCCGAATTCGCTAATTACTGCTTATCTTATTG
Additional information primer 3N0433
Sequence Primer 4GGGGTCTAGAGTAATAAATGTACTGTATGTG
Additional information primer 4N0434
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6